| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 312 | 2021 |
| Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel ER Adams, M Ainsworth, R Anand, MI Andersson, K Auckland, JK Baillie, ... Wellcome Open Research 5, 139, 2020 | 238 | 2020 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study A Angyal, S Longet, SC Moore, RP Payne, A Harding, T Tipton, ... The Lancet Microbe 3 (1), e21-e31, 2022 | 188 | 2022 |
| T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses A Ogbe, B Kronsteiner, DT Skelly, M Pace, A Brown, E Adland, K Adair, ... Nature communications 12 (1), 2055, 2021 | 129 | 2021 |
| MAIT cell activation augments adenovirus vector vaccine immunogenicity NM Provine, A Amini, LC Garner, AJ Spencer, C Dold, C Hutchings, ... Science 371 (6528), 521-526, 2021 | 116 | 2021 |
| Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays E Adams, M Ainsworth, R Anand, MI Andersson, K Auckland, JK Baillie, ... MedRxiv, 2020 | 101 | 2020 |
| Morbillivirus v proteins exhibit multiple mechanisms to block type 1 and type 2 interferon signalling pathways SK Chinnakannan, SK Nanda, MD Baron PloS one 8 (2), e57063, 2013 | 90 | 2013 |
| Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 CP Thompson, NE Grayson, RS Paton, JS Bolton, J Lourenco, ... Eurosurveillance 25 (42), 2000685, 2020 | 85 | 2020 |
| Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors-a pilot study of the value of serology to determine population exposure CP Thompson, N Grayson, R Paton, JS Bolton, J Lourenço, B Penman, ... | 56 | 2020 |
| The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes A von Delft, TA Donnison, J Lourenço, C Hutchings, CE Mullarkey, ... Vaccine 36 (2), 313-321, 2018 | 47 | 2018 |
| Detection of Peste Des Petits Ruminants Virus Antigen in Sheep or Goats Using Immuno Filtration or Antigen Competition ELISA Methods GD Raj, TMC Rajanathan, CS Kumar, V Thiagarajan, MS Shaila Veterinary Microbiology 129 (3-4), 246-251, 2007 | 37* | 2007 |
| The design and development of a multi-HBV antigen encoded in chimpanzee adenoviral and modified vaccinia Ankara viral vectors; a novel therapeutic vaccine strategy against HBV SK Chinnakannan, TN Cargill, TA Donnison, MA Ansari, S Sebastian, ... Vaccines 8 (2), 184, 2020 | 35 | 2020 |
| Use of an outbred rat hepacivirus challenge model for design and evaluation of efficacy of different immunization strategies for hepatitis C virus E Atcheson, W Li, CM Bliss, S Chinnakannan, K Heim, H Sharpe, ... Hepatology 71 (3), 794-807, 2020 | 33 | 2020 |
| NK cells limit therapeutic vaccine–induced CD8+T cell immunity in a PD-L1–dependent manner MO Diniz, A Schurich, SK Chinnakannan, M Duriez, KA Stegmann, ... Science Translational Medicine 14 (640), eabi4670, 2022 | 31 | 2022 |
| Performance of RT-PCR-ELISA for the detection of peste des petits ruminants virus CS Kumar, GD Raj, A Thangavelu, MS Shaila Small Ruminant Research 72 (2-3), 200-208, 2007 | 24 | 2007 |
| Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza A virus challenge CM Tully, S Chinnakannan, CE Mullarkey, M Ulaszewska, F Ferrara, ... The Journal of Immunology 199 (4), 1333-1341, 2017 | 23 | 2017 |
| Different functions of the common P/V/W and V-specific domains of rinderpest virus V protein in blocking IFN signalling SK Chinnakannan, B Holzer, BS Bernardo, SK Nanda, MD Baron Journal of General Virology 95 (1), 44-51, 2014 | 23 | 2014 |
| A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice T Donnison, J McGregor, S Chinnakannan, C Hutchings, RJ Center, ... Hepatology 76 (4), 1190-1202, 2022 | 22 | 2022 |
| Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes T Donnison, A von Delft, A Brown, L Swadling, C Hutchings, T Hanke, ... Vaccine 38 (32), 5036-5048, 2020 | 17 | 2020 |
| Oxford Immunology Network Covid-19 Response T Cell Consortium A Ogbe, B Kronsteiner, DT Skelly, M Pace, A Brown, E Adland, K Adair, ... Oxford Protective T Cell Immunology for COVID-19 (OPTIC) Clinical Team. T …, 2021 | 15 | 2021 |
Eleanor BarnesOxford UniversityVerificeret mail på ndm.ox.ac.uk